Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients

Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006

(2011) T Evans et al.   BRITISH JOURNAL OF CANCER

Cancer statistics, 2011

(2011) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Analysis of Circulating MicroRNA: Preanalytical and Analytical Challenges

(2011) J. S. McDonald et al.   CLINICAL CHEMISTRY

Revised FIGO Staging System for Endometrial Cancer

(2011) SHARYN N. LEWIN   CLINICAL OBSTETRICS AND GYNECOLOGY

A microRNA survival signature (MiSS) for advanced ovarian cancer

(2011) Karin K. Shih et al.   GYNECOLOGIC ONCOLOGY

Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1

(2011) T.K.H. Chung et al.   INTERNATIONAL JOURNAL OF CANCER

Crosstalk Between Estrogen Receptor and Mitogen-Activated Protein Kinase Signaling in the Development and Progression of Endometrial Cancer

(2011) Long Zhou et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Clinical Impact of Down-Regulated Plasma miR-92a Levels in Non-Hodgkin's Lymphoma

(2011) Kazuma Ohyashiki et al.   PLoS One

The MicroRNA-200 Family Is Upregulated in Endometrial Carcinoma

(2011) Jaime Snowdon et al.   PLoS One

AMG 479, a Novel IGF-1-R Antibody, Inhibits Endometrial Cancer Cell Proliferation Through Disruption of the PI3K/Akt and MAPK Pathways

(2011) Albert Mendivil et al.   Reproductive Sciences

Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer

(2010) Seung-Su Han et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Comprehensive miRNA profiling of surgically staged endometrial cancer

(2010) David E. Cohn et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Estimates of cancer incidence and mortality in Europe in 2008

(2010) J. Ferlay et al.   EUROPEAN JOURNAL OF CANCER

MicroRNA signatures differentiate uterine cancer tumor subtypes

(2010) Elena S. Ratner et al.   GYNECOLOGIC ONCOLOGY

The expression of the miRNA-200 family in endometrial endometrioid carcinoma

(2010) Jeong-Won Lee et al.   GYNECOLOGIC ONCOLOGY

miRNAs in human cancer

(2010) Thalia A Farazi et al.   JOURNAL OF PATHOLOGY

mRNA and microRNA quality control for RT-qPCR analysis

(2010) C. Becker et al.   METHODS

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)

(2010) Evan M. Kroh et al.   METHODS

Mammalian microRNAs predominantly act to decrease target mRNA levels

(2010) Huili Guo et al.   NATURE

Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development

(2010) Masatoshi Shigoka et al.   PATHOLOGY INTERNATIONAL

DIANA-mirPath: Integrating human and mouse microRNAs in pathways

(2009) G. L. Papadopoulos et al.   BIOINFORMATICS

Definition of microRNAs That Repress Expression of the Tumor Suppressor Gene FOXO1 in Endometrial Cancer

(2009) S. S. Myatt et al.   CANCER RESEARCH

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma

(2009) Mayuko Furuta et al.   CARCINOGENESIS

Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer

(2009) Zhaohui Huang et al.   INTERNATIONAL JOURNAL OF CANCER

Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients

(2009) Masami Tanaka et al.   PLoS One

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

(2008) Xi Chen et al.   CELL RESEARCH

Expression profile of mammalian microRNAs in endometrioid adenocarcinoma

(2008) Weiguang Wu et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis

(2008) Todd Boren et al.   GYNECOLOGIC ONCOLOGY

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

(2008) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY

Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women

(2008) Tony K.H. Chung et al.   INTERNATIONAL JOURNAL OF CANCER

Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro

(2008) Silvia Darb-Esfahani et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR

(2008) U Siebolts et al.   JOURNAL OF CLINICAL PATHOLOGY

An Array-Based Analysis of MicroRNA Expression Comparing Matched Frozen and Formalin-Fixed Paraffin-Embedded Human Tissue Samples

(2008) Xiao Zhang et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

(2008) Philip A. Gregory et al.   NATURE CELL BIOLOGY

Circulating microRNAs as stable blood-based markers for cancer detection

(2008) P. S. Mitchell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissues

(2008) H. J. Peltier et al.   RNA